| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |